From: Cancer stem-like cell: a novel target for nasopharyngeal carcinoma therapy
Expression/functional profile | Cells/tissues studied | Characteristics of cancer stem cell identity |
---|---|---|
Label-retaining cells | 5-8Â F, 6-10B and TMNE | Increased clonogenicity, tumor formation in mice at low titers [16, 17] |
Label-retaining cells (PKH26+) | CNE1, CNE2, SUNE1, and HONE1 | Longevity, sphere formation, side population cells, and resistance to radiotherapy [18] |
Side population cells | CNE-2 | Strong tumorigenesis ability, more resistant to chemotherapy and radiotherapy, cytokine 19 positive [24] |
Side population cells (ABCG2+) | 5-8 F | ABCG2 alone is not sufficient, PSCA, ABCG2 and ALP were expressed in ABCG2+ cells, and K19, integrin α6, integrin β4, CD44 and K14 were expressed in ABCG2− cells [25] |
ALDH1high cells or ALDH1A1 | 5-8 F and CNE2 | High ALDH1 activity, higher clone formation efficiency, differentiation capability and higher migration, enhanced capacities of growth, proliferation, and tumorigenesis,5 to 103 ALDH1high NPC cells required to induce tumors, vimentin+, and E-cadherin−,OCT4, SOX2 and Nanog+[27, 28] |
C666-1 | Significantly greater ability to proliferate, be clonogenic, resist chemotherapy drugs and radiation, and express pluripotent markers, tumor formation at a higher rate [29–31] | |
CD44+ | 5-8Â F, C666-1 | |
CD133+ | CNE2 and primarily cultured NPC cells | Nanog+ and Sox2+, a strong potential for self-renewal, sphere formation, proliferation and differentiation and a greater potential for in vivo tumor formation in nude mice [39] |
Sphere-forming cells | C666-1 | CD44+ and SOX2+, higher spheroid formation efficiency, resistant to chemotherapeutic agents, CCR7+ associated recurrent disease and distant metastasis [48] |